
Acceleris Capital
Europe, Manchester, United Kingdom, Manchester'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Acceleris Capital provides corporate finance advice and raises funds for early and development stage businesses.
Investor Profile
Acceleris Capital has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 18% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Private Equity rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Singapore.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series Unknown (65%)
- Seed (24%)
- Private Equity (6%)
- Series A (6%)
Country Focus
- United Kingdom (88%)
- United States (6%)
- Singapore (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Chemical
- Farming
- Agriculture
- Medical
- Manufacturing
- Biopharma
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.